DE4103360A1 - Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen - Google Patents

Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen

Info

Publication number
DE4103360A1
DE4103360A1 DE19914103360 DE4103360A DE4103360A1 DE 4103360 A1 DE4103360 A1 DE 4103360A1 DE 19914103360 DE19914103360 DE 19914103360 DE 4103360 A DE4103360 A DE 4103360A DE 4103360 A1 DE4103360 A1 DE 4103360A1
Authority
DE
Germany
Prior art keywords
agent
bronchitis
bronchial asthma
cysteine
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19914103360
Other languages
English (en)
Inventor
Peter Kohler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19914103360 priority Critical patent/DE4103360A1/de
Publication of DE4103360A1 publication Critical patent/DE4103360A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Beschreibung
Acetyl-Cystein, von der isotonischen Trägerflüssigkeit NaCl - Natriumchlorid in die tierischen - menschlichen Zellen diffundiert, repariert durch das enthaltene Cystein/Cystin den beim Allergiker bestehenden Einweiß-Enzymdefekt.
(Beispiel: ADA - Adenosin-Desaminase-Enzymmangel)
Das über Pyruvat entstandene Acetyl-CoA aktiviert und synthetisiert diverse Steroidhormone und Neurotransmitter wie z. B. Acetylcholin und Dopamin und im Citratzyklus (Atmungskette) entstandenes ADP und ATP.
Dieselben sind unter anderem wichtig für die Muskel-An-und-Entspannung (Verkrampfung der Bronchien, Brochiolen bei Bronchitis, Asthma Bronchiale).
Anwendung
Acetylcystein-NaCl muß oral substituiert werden um über den Magen-Darmtrakt durch die Pfortader hämatogen in die Leber (die tierische Chemiefabrik) und die übrigen Organe zu gelangen.
Anwendung nur in größerem Zeitintervall - Übersteuerungsgefahr (Feedback).
Nebenwirkungen
Ph-Wert-Verschiebung durch vermehrten CO₂-Anfall Serumcalcium-Mangel durch Oxalsäureüberschuß möglich.

Claims (1)

  1. Der Wirkstoff Acetylcystein kombiniert mit der isotonischen Kochsalzlösung NaCl - Natriumchlorid 0,9% als Trägerflüssigkeit (Carrier).
DE19914103360 1991-02-05 1991-02-05 Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen Ceased DE4103360A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19914103360 DE4103360A1 (de) 1991-02-05 1991-02-05 Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914103360 DE4103360A1 (de) 1991-02-05 1991-02-05 Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen

Publications (1)

Publication Number Publication Date
DE4103360A1 true DE4103360A1 (de) 1992-08-06

Family

ID=6424376

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19914103360 Ceased DE4103360A1 (de) 1991-02-05 1991-02-05 Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen

Country Status (1)

Country Link
DE (1) DE4103360A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4406261A1 (de) * 1993-08-31 1995-03-02 Deutsches Krebsforsch Mittel zur Verminderung der Körperfettmenge
WO2010090612A1 (en) * 2009-02-05 2010-08-12 Bilgic Mahmut Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
WO2010090611A3 (en) * 2009-02-05 2011-02-03 Bilgic Mahmut Taste and odor masked pharmaceutical compositions with high bioavailability
IT201700109080A1 (it) * 2017-09-28 2019-03-28 Neilos S R L Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146570A1 (de) * 1980-12-06 1982-07-08 Dr.med. Dietrich Ibiza Reichert Mittel zur bekaempfung des schnarchens
DE3723735A1 (de) * 1986-07-24 1988-02-04 Inpharzam Int Sa Pharmazeutische, n-acetylcystein enthaltende, wasserloesliche zusammensetzung
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146570A1 (de) * 1980-12-06 1982-07-08 Dr.med. Dietrich Ibiza Reichert Mittel zur bekaempfung des schnarchens
DE3723735A1 (de) * 1986-07-24 1988-02-04 Inpharzam Int Sa Pharmazeutische, n-acetylcystein enthaltende, wasserloesliche zusammensetzung
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOSER, U.:"DAZ-Fortbildung Pharmakologie 29", in DAZ, 123 Jg., Nr. 45, 10.11.1983, S. 243-251 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4406261A1 (de) * 1993-08-31 1995-03-02 Deutsches Krebsforsch Mittel zur Verminderung der Körperfettmenge
WO2010090612A1 (en) * 2009-02-05 2010-08-12 Bilgic Mahmut Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
WO2010090611A3 (en) * 2009-02-05 2011-02-03 Bilgic Mahmut Taste and odor masked pharmaceutical compositions with high bioavailability
IT201700109080A1 (it) * 2017-09-28 2019-03-28 Neilos S R L Composizione per la prevenzione e/o il trattamento delle affezioni delle vie respiratorie
WO2019064255A1 (en) * 2017-09-28 2019-04-04 Neilos S.r.l. COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF RESPIRATORY TRACT
US11351213B2 (en) 2017-09-28 2022-06-07 Neilos S.r.l. Composition for the prevention and/or treatment of respiratory tract disorders

Similar Documents

Publication Publication Date Title
Kowarski et al. Active transport of zinc and identification of zinc-binding protein in rat jejunal mucosa
Evans The toxicity of hydrogen sulphide and other sulphides
US2786014A (en) Platelet preservation
Franchitto et al. Acute copper sulphate poisoning: a case report and literature review
Khan et al. Effect of aluminium metal on glutathione (GSH) level in plasma and cytosolic fraction of human blood
ATE59298T1 (de) Praeparate zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung derartiger praeparate.
Baker Transport phenomena in plants
DE4103360A1 (de) Medikament zur linderung und heilung von asthma bronchiale und anderen lungenerkrankungen
KR840005342A (ko) 정맥투여용 수액제의 제조방법
Nachman Taste preferences for lithium chloride by adrenalectomized rats
ATE6925T1 (de) Verfahren zur reinigung von gallium enthaltenden loesungen.
Grøn et al. An investigation of the state of carbon dioxide in human saliva
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
Lindinger et al. Muscle and blood acid-base physiology during exercise and in response to training
ATE553116T1 (de) Metall bindende verbindungen und ihre verwendungen
Mykkanen et al. Relationship of membrane-bound sulfhydryl groups to vitamin D-stimulated uptake of [75Se] Selenite by the brush border membrane vesicles from chick duodenum
NASR Biochemical aspects of ozone intoxication: a review
Bibby et al. Fluorine and titanium and the organic material of dental enamel
Colombetti Biological Transport: An Historical View
JPS58189104A (ja) 木材用防腐組成物
Branca et al. Diamide effect on the hypertonic calcium uptake by rat red blood cells
Olson et al. Investigation of the accompaniment of calcium during active calcium transport from human erythrocyte ghosts
Belokonova et al. Chemistry: Tutorial for practical and laboratory works in Chemistry for the first year students of the faculties of General Medicine and Pediatrics in English
US277810A (en) teachman
Barile Gases

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection